Award
NIH Reporter #5R01NS122395-05
Understanding the Behavior of Novel IL13Ralpha2-directed T cell Engager for GBM
Recipient
Northwestern University, Chicago, IL
Award Amount
$348,526.00
Ceiling
$348,526.00
Awarded
March 26, 2025
Identifier
5R01NS122395-05
This NIH grant supports research on a novel T cell engager targeting IL13Rα2 for glioblastoma treatment, aiming to improve tumor targeting and immune response in preclinical models.
Description
Research grant focused on developing immunotherapy for glioblastoma using BiTE molecules targeting IL13Rα2. The project involves preclinical testing, mechanism studies, and regimen development for potential clinical application.